1-6 of 6
Michael S Mathisen
Close
Sort by
Journal Articles

Comparative Analysis of the Value of Consolidation with Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) Versus High-Dose Cytarabine (HDAC) Based Chemotherapy in Patients (pts) with Acute Myeloid Leukemia (AML) with Chromosome Seven Abnormalities

Elias J. Jabbour, MD, Hagop M. Kantarjian, MD, Betul Oran, MD, MS, Farhad Ravandi, MD, Hady Ghanem, MD, Issa Khouri, MD, Guillermo Garcia-Manero, MD, Michael S Mathisen, PharmD, Qaiser Bashir, MD, Rima M Saliba, PhD, Maria Khouri, Sherry A. Pierce, RN, BS, Mark Brandt, BS, Richard E. Champlin, Marcos De Lima, MD
Journal: Blood
Blood (2012) 120 (21): 2029.
https://doi.org/10.1182/blood.V120.21.2029.2029
Published: 2012
Journal Articles

Dynamics of Molecular Response in Patients (pts) with Acute Myeloid Leukemia (AML) Withy Core Binding Factor (CBF) Abnormalities Treated with High-Dose Cytarabine Regimen

Elias J. Jabbour, MD, Hagop M. Kantarjian, MD, Yin Cameron, MD, PhD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Hady Ghanem, MD, Tapan M. Kadia, M.D., Stefan Faderl, MD, Susan O'Brien, M.D., Michael S Mathisen, PharmD, Mark Brandt, BS, Naveen Pemmaraju, M.D., Deborah A. Thomas, MD, Joyce Bass, RN, Gautam Borthakur
Journal: Blood
Blood (2012) 120 (21): 3609.
https://doi.org/10.1182/blood.V120.21.3609.3609
Published: 2012
Journal Articles

Updated Results of a Phase I/II, Randomized Study of Clofarabine Combined with Idarubicin and Cytarabine (CIA) or Fludarabine Combined with Idarubicin and Cytarabine (FIA) for the Treatment of Patients (pts) with Newly Diagnosed or Relapsed/Refractory (RR) Acute Myeloid Leukemia (AML)

Michael S Mathisen, PharmD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Naveen Pemmaraju, M.D., Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Susan O'Brien, M.D., Alfonso Quintas-Cardama, MD, Hady Ghanem, MD, Naval G. Daver, MD, Sherry A. Pierce, RN, BS, Cynthia Lira, RN, Stefan Faderl, MD, Elias Jabbour, MD
Journal: Blood
Blood (2012) 120 (21): 3610.
https://doi.org/10.1182/blood.V120.21.3610.3610
Published: 2012
Journal Articles

Infectious Complications in Patients with Relapsed Acute Myeloid Leukemia (AML) Receiving Clofarabine Versus Fludarabine-Containing Salvage Chemotherapy Regimens

Michael S Mathisen, PharmD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Stefan Faderl, MD, Gautam Borthakur, M.D., Jorge E. Cortes, MD, Alfonso Quintas-Cardama, MD
Journal: Blood
Blood (2012) 120 (21): 4322.
https://doi.org/10.1182/blood.V120.21.4322.4322
Published: 2012
Journal Articles

Clofarabine-Containing Chemotherapy Does Not Increase the Risk of Infectious Complications in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Michael S Mathisen, Hagop M Kantarjian, Elias Jabbour, MD, Guillermo Garcia-Manero, Farhad Ravandi, MD, Stefan Faderl, MD, Gautam Borthakur, Jorge E. Cortes, Alfonso Quintás-Cardama, MD
Journal: Blood
Blood (2011) 118 (21): 4256.
https://doi.org/10.1182/blood.V118.21.4256.4256
Published: 2011
Journal Articles

Clofarabine Does Not Impact Negatively the Outcomes of Patients with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Stem Cell Transplantation and Is Not Associated with Higher Liver Toxicity Rates Compared with Standard Chemotherapy

Michael S Mathisen, Hagop M. Kantarjian, Elias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi, MD, Stefan Faderl, MD, Gautam Borthakur, Jorge E. Cortes, Alfonso Quintas-Cardama, MD
Journal: Blood
Blood (2011) 118 (21): 1489.
https://doi.org/10.1182/blood.V118.21.1489.1489
Published: 2011